Patents Assigned to Eli Lilly & Company Lilly Corporate Center
  • Potassium channel inhibitors
    Patent number: 6174908
    Abstract: Certain thiazolidinone and metathiazanone compounds, as described, are useful as potassium channel inhibitors and are especially useful for the treatment of cardiac arrhythmias and other diseases, conditions and disorders.
    Type: Grant
    Filed: May 1, 1999
    Date of Patent: January 16, 2001
    Assignees: ICAGen, Inc., Eli Lilly & Company Lilly Corporate Center
    Inventors: Michael F. Gross, Neil A. Castle, Jose S. Mendoza